Serum adiponectin is a negative predictor of central arterial stiffness in kidney transplant patients

References

• Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725–30.
   PubMed Web of Science ®Google Scholar
• Glicklich D, Vohra P. Cardiovascular risk assessment before and after kidney transplantation. Cardiol Rev 2014;22:153–62.
   PubMed Web of Science ®Google Scholar
• Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM, Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 2014;383:1831–43.
   PubMed Web of Science ®Google Scholar
• Hart A, Weir M, Kasiske B. Cardiovascular risk assessment in kidney transplantation. Kidney Int 2015;87:527–34.
   PubMed Web of Science ®Google Scholar
• Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236–41.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318–27.
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H, European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605.
   PubMed Web of Science ®Google Scholar
• Ruster C, Wolf G. Adipokines promote chronic kidney disease. Nephrol Dial Transplant 2013;28:iv8–14.
   PubMed Web of Science ®Google Scholar
• Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959–71.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29–33.
   PubMed Web of Science ®Google Scholar
• Tsiakou A, Liatis S, Alexiadou K, Diakoumopoulou E, Makrilakis K, Tentolouris N, Kyriaki D, Katsilambros N. Arterial stiffness is inversely related to plasma adiponectin levels in young normotensive patients with type 1 diabetes. Diabetes Care 2013;36:734–6.
   PubMed Web of Science ®Google Scholar
• Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, Oguro R, Kamide K, Rakugi H. Adiponectin single nucleotide polymorphism is a genetic risk factor for stroke through high pulse wave pressure: a cohort study. J Atheroscler Thromb 2013;20:152–60.
   PubMed Web of Science ®Google Scholar
• Kohara K, Ochi M, Okada Y, Yamashita T, Ohara M, Kato T, Nagai T, Tabara Y, Igase M, Miki T. Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage. Atherosclerosis 2014;235:424–9.
   PubMed Web of Science ®Google Scholar
• Hui E, Xu A, Chow WS, Lee PC, Fong CH, Cheung SC, Tse HF, Chau MT, Cheung BM, Lam KS. Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study. Metab Syndr Relat Disord 2014;12:517–22.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications.. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diagnosis classification diabetes provisional of WHO. Diabet Med 1998;15:539–53.
   PubMed Web of Science ®Google Scholar
• Lee MC, Lee CJ, Chou KC, Shih MH, Hsu BG. Hypoadiponectinemia correlates with metabolic syndrome in kidney transplantation patients. Transplant Proc 2011;43:2601–5.
   PubMed Web of Science ®Google Scholar
• Chen YC, Lee MC, Lee CJ, Ho GJ, Yin WY, Chang YJ, Hsu BGN. Terminal pro-B-type natriuretic peptide associated with arterial stiffness by cardio-ankle vascular index in renal transplant recipients. J Atheroscler Thromb 2013;20:646–53.
   PubMed Web of Science ®Google Scholar
• Lee MC, Chen YC, Ho GJ, Shih MH, Chou KC, Hsu BG. Serum leptin levels positively correlate with peripheral arterial stiffness in kidney transplantation patients. Transplant Proc 2014;46:353–8.
   PubMed Web of Science ®Google Scholar
• Wang JH, Lee CJ, Chen ML, Yang CF, Chen YC, Hsu BG. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. J Clin Hypertens (Greenwich) 2014;16:301–8.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Wang JH, Chen YC, Chen ML, Yang CF, Hsu BG. Serum osteopontin level correlates with carotid-femoral pulse wave velocity in geriatric persons. BioMed Res Int 2014;2014:570698
   PubMedGoogle Scholar
• Sabbatini AR, Fontana V, Laurent S, Moreno H. An update on the role of adipokines in arterial stiffness and hypertension. J Hypertens 2015;33:435–44.
   PubMed Web of Science ®Google Scholar
• Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol 2009;103:1411–16.
   PubMed Web of Science ®Google Scholar
• Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Schaefer EJ. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham Offspring Study. Atherosclerosis 2011;217:543–8.
   PubMed Web of Science ®Google Scholar
• Wu Z, Cheng Y, Aung LHH, Li B. Association between adiponectin concentrations and cardiovascular disease in metabolic patients: a systemic review and meta-analysis. PLoS One 2013;8:e78485
   Google Scholar
• Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–357.
   PubMed Web of Science ®Google Scholar
• The Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values.” European Heart J 2010;31:2338–50.
   PubMed Web of Science ®Google Scholar
• Verbeke F, Van Biesen W, Peeters P, Van Bortel LM, Vanholder RC. Arterial stiffness and wave reflections in renal transplant recipients. Nephrol Dial Transplant 2007;22:3021–7.
   PubMed Web of Science ®Google Scholar
• Strozecki P, Adamowicz A, Włodarczyk Z, Manitius J. Factors associated with increased arterial stiffness in renal transplant recipients. Med Sci Monit 2010;16:CR301
   Google Scholar
• Verbeke F, Maréchal C, Van Laecke S, Van Biesen W, Devuyst O, Van Bortel LM, Jadoul M, Vanholder R. Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension 2011;58:833–8.
   PubMed Web of Science ®Google Scholar
• Woodard T, Sigurdsson S, Gotal JD, Torjesen AA, Inker LA, Aspelund T, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Levey AS, Mitchell GF. Mediation analysis of aortic stiffness and renal microvascular function. J Am Soc Nephrol 2015;26:1181–7.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Saito S, Daitoku K, Fukuda I, Higuma T, Hanada H, Osanai T, Okumura K. Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease. Fundam Clin Pharmacol 2011;25:378–87.
   PubMed Web of Science ®Google Scholar
• Takagi T, Matsuda M, Abe M, Kobayashi H, Fukuhara A, Komuro R, Kihara S, Caslake MJ, McMahon A, Shepherd J, Funahashi T, Shimomura I. Effect of pravastatin on the development of diabetes and adiponectin production. Atherosclerosis 2008;196:114–21.
   PubMed Web of Science ®Google Scholar
• Yin WH, Jen HL, Chen JW, Lin SJ, Young MS. Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia. Diabetes Metab 2006;32:229–35.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Sakamoto T, Ogawa H. Kumamoto Joint Research on Hypercholesterolemia Investigators. The effect of 6 months of treatment with pravastatin on serum adiponectin concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study. Clin Ther 2006;28:1012–21.
   PubMed Web of Science ®Google Scholar